Author:
Piro L.D.,White C.A.,Grillo-López A.J.,Janakiraman N.,Saven A.,Beck T.M.,Varns C.,Shuey S.,Czuczman M.,Lynch J.W.,Kolit J.E.,Jain V.
Reference19 articles.
1. Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody;Miller;N Engl J Med,1982
2. IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma;Maloney;Blood,1997
3. The B-cell surface molecule Bl is functionally linked with B-cell activation and differentiation;Tedder;J Immunol,1985
4. Antibodies reactive with the Bl molecule inhibit cell cycle progression but not activation of human B lymphocytes;Tedder;Eur J Immunol,1986
5. PCL B. The CD20 (Bp35) antigen is involved in activation of B cells from the GO to the G1 phase of the cell cycle;Golay;J Immunol,1985
Cited by
339 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献